Generation of dopamine neurons in vivo and from embryonic stem cells in vitro
Author: Friling, Stina
Date: 2009-03-27
Location: I Cell- och molekylärbiologiska institutionens auditorium, Berzelius väg 21
Time: 09.30
Department: Institutionen för cell- och molekylärbiologi (CMB) / Department of Cell and Molecular Biology
View/ Open:
Thesis (963.0Kb)
Abstract
Mesencephalic dopamine (mesDA) neurons degenerate in patients with Parkinson s disease. In order to develop new treatment strategies for rescuing or replacing degenerating mesDA neurons, an improved understanding of the development and survival of these neurons in the normal brain is required.
In paper I we identify two key players, Lmx1a and Msx1, implicated in the specification of mesDA neurons. Lmx1a and Msx1 are important for ensuring the correct mesDA neuron differentiation cascade by suppressing alternative cell fates, promoting neurogenesis and inducing the generation of mesDA neurons.
In papers I and II we provide evidence that over-expression of Lmx1a both in mouse and human embryonic stem cells leads to an efficient generation of authentic mesDA neurons. These in vitro engineered mesDA neurons might, in the future, be used as a cell source in cell replacement therapy for patients with Parkinson s disease. However, to ensure a safe treatment, the use of embryonic stem cells depends on avoiding adverse effects such as uncontrolled cell growth.
In papers II and III we show that an enrichment for embryonic stem cellderived progenitor cells or mature neurons, prior to grafting, removes unwanted dividing cells. Moreover, a higher number of mesDA neurons are present in the grafts after transplantation of sorted neurons, compared to progenitor cells.
In paper IV, we show that ligands for the retinoic X receptor are present in the mesDA neuron domain in vivo, and that they mediate neuronal survival in primary mesDA neurons expressing both Nurr1 and the retinoic X receptor. These factors might be of interest as a potential treatment strategy to enhance survival of endogenous or transplanted mesDA neurons for patients with Parkinson s disease.
The work presented in this thesis has increased the knowledge concerning the development of mesDA neurons and has helped to establish a protocol enabling the production of highly purified mesDA neurons. This knowledge can facilitate the establishment of new therapies for patients with Parkinson s disease, be a useful tool in drug screenings and help to identify additional factors important for the development, survival and maintenance of the mesDA system.
In paper I we identify two key players, Lmx1a and Msx1, implicated in the specification of mesDA neurons. Lmx1a and Msx1 are important for ensuring the correct mesDA neuron differentiation cascade by suppressing alternative cell fates, promoting neurogenesis and inducing the generation of mesDA neurons.
In papers I and II we provide evidence that over-expression of Lmx1a both in mouse and human embryonic stem cells leads to an efficient generation of authentic mesDA neurons. These in vitro engineered mesDA neurons might, in the future, be used as a cell source in cell replacement therapy for patients with Parkinson s disease. However, to ensure a safe treatment, the use of embryonic stem cells depends on avoiding adverse effects such as uncontrolled cell growth.
In papers II and III we show that an enrichment for embryonic stem cellderived progenitor cells or mature neurons, prior to grafting, removes unwanted dividing cells. Moreover, a higher number of mesDA neurons are present in the grafts after transplantation of sorted neurons, compared to progenitor cells.
In paper IV, we show that ligands for the retinoic X receptor are present in the mesDA neuron domain in vivo, and that they mediate neuronal survival in primary mesDA neurons expressing both Nurr1 and the retinoic X receptor. These factors might be of interest as a potential treatment strategy to enhance survival of endogenous or transplanted mesDA neurons for patients with Parkinson s disease.
The work presented in this thesis has increased the knowledge concerning the development of mesDA neurons and has helped to establish a protocol enabling the production of highly purified mesDA neurons. This knowledge can facilitate the establishment of new therapies for patients with Parkinson s disease, be a useful tool in drug screenings and help to identify additional factors important for the development, survival and maintenance of the mesDA system.
List of papers:
I. Andersson E, Tryggvason U, Deng Q, Friling S, Alekseenko Z, Robert B, Perlmann T, Ericson J (2006). Identification of intrinsic determinants of midbrain dopamine neurons. Cell. 124(2): 393-405.
Pubmed
View record in Web of Science®
II. Frilling S, Andersson E, Thompson LH, Jönsson ME, Hebsgaard JB, Nanou E, Alekseenko Z, Marklund U, Kjellander S, Volakakis N, Hovatta O, El Manira A, Björklund A, Perlmann T, Ericson J (2009). Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc Natl Acad Sci USA. [Accepted]
Pubmed
View record in Web of Science®
III. Friling S, Andersson E, Azevedo S, Alekseenko Z (2009). Enrichment of embryonic stem cellderived dopamine neurons for transplantation by fluorescence-activated cell sorting. [Manuscript]
IV. Wallen-Mackenzie A, Mata de Urquiza A, Petersson S, Rodriguez FJ, Friling S, Wagner J, Ordentlich P, Lengqvist J, Heyman RA, Arenas E, Perlmann T (2003). Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells. Genes Dev. 17(24): 3036-47.
Pubmed
View record in Web of Science®
I. Andersson E, Tryggvason U, Deng Q, Friling S, Alekseenko Z, Robert B, Perlmann T, Ericson J (2006). Identification of intrinsic determinants of midbrain dopamine neurons. Cell. 124(2): 393-405.
Pubmed
View record in Web of Science®
II. Frilling S, Andersson E, Thompson LH, Jönsson ME, Hebsgaard JB, Nanou E, Alekseenko Z, Marklund U, Kjellander S, Volakakis N, Hovatta O, El Manira A, Björklund A, Perlmann T, Ericson J (2009). Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc Natl Acad Sci USA. [Accepted]
Pubmed
View record in Web of Science®
III. Friling S, Andersson E, Azevedo S, Alekseenko Z (2009). Enrichment of embryonic stem cellderived dopamine neurons for transplantation by fluorescence-activated cell sorting. [Manuscript]
IV. Wallen-Mackenzie A, Mata de Urquiza A, Petersson S, Rodriguez FJ, Friling S, Wagner J, Ordentlich P, Lengqvist J, Heyman RA, Arenas E, Perlmann T (2003). Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells. Genes Dev. 17(24): 3036-47.
Pubmed
View record in Web of Science®
Issue date: 2009-03-06
Rights:
Publication year: 2009
ISBN: 978-91-7409-392-6
Statistics
Total Visits
Views | |
---|---|
Generation ...(legacy) | 718 |
Generation ... | 102 |
Total Visits Per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Generation ... | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
File Visits
Views | |
---|---|
thesis.pdf(legacy) | 530 |
thesis.pdf | 225 |
thesis.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 328 |
Sweden | 72 |
China | 56 |
Germany | 50 |
Finland | 14 |
South Korea | 14 |
United Kingdom | 11 |
Russia | 7 |
Denmark | 6 |
France | 6 |
Top cities views
Views | |
---|---|
Romeo | 27 |
Beijing | 25 |
Sunnyvale | 21 |
Kiez | 17 |
Stockholm | 15 |
Seoul | 14 |
Shenzhen | 9 |
Helsinki | 8 |
Mountain View | 8 |
Woodbridge | 8 |